MDV Pharma
0742.814.914 · rovalta.com · 08/11/2026
MDV Pharma
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMDV Pharma is a Private limited company incorporated in 2020. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Genappe.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0742.814.914
- Incorporation
- 03/02/2020
- Legal form
- Private limited company
- Registered office
- Rue de Villers-la-Ville 78
1470 Genappe · WallonieSee on map - Contributed capital
- 2 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 24,2 k € | -3.3% | 25 k € | -30.9% | 36,2 k € | +132% | 15,6 k € | -73.9% | 59,6 k € |
| EBITDA | 23,9 k € | +25.1% | 19,1 k € | -46.1% | 35,4 k € | +133% | 15,2 k € | -74.4% | 59,2 k € |
| Operating result | 16 k € | +44.5% | 11,1 k € | -63.1% | 30,1 k € | +199% | 10,1 k € | -81.4% | 54,2 k € |
| Net result | 258,4 k € | +174% | 94,4 k € | -44.9% | 171,5 k € | +382718% | -44,8 € | -100% | 42,5 k € |
| Balance sheet | |||||||||
| Equity | 475,2 k € | +78.2% | 266,7 k € | +11.0% | 240,3 k € | +177% | 86,8 k € | -0.1% | 86,8 k € |
| Total assets | 1,7 M € | +7.9% | 1,6 M € | +1.6% | 1,6 M € | +3.1% | 1,5 M € | +1003% | 137,4 k € |
| Cash | 77,7 k € | +21.2% | 64,1 k € | -44.0% | 114,4 k € | +503% | 19 k € | -82.3% | 107 k € |
| Debts | 1,2 M € | -5.8% | 1,3 M € | -0.7% | 1,3 M € | -7.5% | 1,4 M € | +2726% | 50,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marie DE VRIESE | DirectorManaging director2023 accountsended | ||
Pierre Clabots | Director |
Other companies at this address
Rue de Villers-la-Ville 78 1470 Genappe| Company | CBE no. |
|---|---|
C.V.H.● Active | 0472.931.418 |
PHARMACIE CLABOTS● Active | 0451.595.376 |
UTVA HOLDING PHARMA● Active | 0650.881.975 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 03/02/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 11 months |
| Filing date | 18/06/2026 | 14/07/2025 | 17/07/2024 | 25/04/2023 | 23/06/2022 | 31/08/2021 |
| General meeting | 05/06/2026 | 30/06/2025 | 31/05/2024 | 23/03/2023 | 31/05/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 05/06/2026 | 18/06/2026 | French | |
| Micro model | 31/12/2024 | 30/06/2025 | 14/07/2025 | French | |
| Micro model | 31/12/2023 | 31/05/2024 | 17/07/2024 | French | |
| Micro model | 31/12/2022 | 23/03/2023 | 25/04/2023 | French | |
| Micro model | 31/12/2021 | 31/05/2022 | 23/06/2022 | French | |
| Micro model | 31/12/2020 | 04/06/2021 | 31/08/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marie DE VRIESE | DirectorManaging director2023 accountsended | ||
Pierre Clabots | Director |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de Villers-la-Ville 78, 1470 GenappeCurrent | CBE | |
| Rue de Villers-la-Ville 56 bte -, 1470 Genappe | accounts 2022 → 2025 | Accounts 2025 · 2026-00170754 |
| Rue de la Liberté 56 bte -, 6230 Pont-à-Celles | accounts 2021 | Accounts 2021 · 2022-20093365 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MDV PharmaCurrent | accounts 2020 → 2025 | Accounts 2025 · 2026-00170754 |
Events
- 2025Annual accounts 2025258,4 k €↑
- 2024Annual accounts 202494,4 k €↓
- 2023Annual accounts 2023171,5 k €↑
- 2022Annual accounts 2022-44,8 €↓
- 2021Annual accounts 202142,5 k €↑
- 2020Annual accounts 202041,8 k €
- 03/02/2020IncorporationPrivate limited company